Clinical Trials Logo

Clinical Trial Summary

The current best practice is a three-stage classification consensus guideline as published by the International Society of Lymphology (ISL). Severity of lymphedema is however not only determined by presence of pitting (which is the phenomenon when the swollen area has a dimple (or pit) after you press it for 5 to 10 seconds) and presence of adipose tissue or not, but is also determined by the volume of the edema, a quantification of the condition of the skin and the location/expansion of the edema over the body. Currently a severity score considering these different aspects does not exist. Although there is consensus that the ISL staging systems is a necessary part of the diagnosis of lymphedema, it gives not enough information about the severity of the lymphedema. A more detailed and comprehensive classification system applicable for primary and secondary lymphedema and considering multiple edema characteristics, remains to be formulated. The researchers objective in this study is to develop a diagnostic set, including a 'severity score', for patients with LLL.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05757284
Study type Observational
Source KU Leuven
Contact Tessa De Vrieze, Dr.
Phone 003216345006
Email tessa.devrieze@kuleuven.be
Status Recruiting
Phase
Start date January 1, 2023
Completion date October 2024